Article Details
Retrieved on: 2024-01-25 00:11:54
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The PIKA Rabies Vaccine, leveraging YS Biopharma's proprietary PIKA adjuvant technology, promises a potentially more rapid and robust immune response ...
Article found on: www.einnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here